Skip to main content
. 2022 Oct 20;23(20):12595. doi: 10.3390/ijms232012595

Figure 3.

Figure 3

Roles of endogenous asprosin in regulating the RSNA, MAP, and HR. (A) Effects of microinjection of anti-asprosin antibody in the PVN on the RSNA, MAP, and HR. * p < 0.05 vs. PBS. † p < 0.05 vs. control antibody. (B) Effects of PVN pretreatment of anti-asprosin antibody on the roles of asprosin in increasing the RSNA, MAP, and HR. The pretreatment was carried out 10 min before the microinjection of asprosin (5 pmol) in the PVN. * p < 0.05 vs. PBS + PBS; † p < 0.05 vs. control antibody + asprosin. Values are given as mean ± SE. n = 6 per group.